Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Kenneth d’Entremont

Kenneth d’Entremont founded Medexus, Inc. Presently, Mr. D’Entremont is Chief Executive Officer & Director at Medexus Pharmaceuticals, Inc.

Mr. D’Entremont previously was President, Chief Executive Officer & Director at Medexus, Inc. and General Manager & VP-Business Development at Sanofi Canada, Inc.

Kenneth d’Entremont received an undergraduate degree from McMaster University.

Transactions

Date Shares Transaction Value
12/13/2022 16,000   1,664,000
12/13/2022 5,000   520,000
12/13/2022 16,000   1,664,000
12/13/2022 4,000   7,640
12/13/2022 16,000   30,720
12/13/2022 4,000   7,640
12/13/2022 16,000   30,720
12/13/2022 1,200   2,304
12/12/2022 16,000   1,664,000
12/12/2022 4,000   7,640
09/21/2022 10,000   11,900
08/25/2022 37,794   0
06/28/2022 10,000   20,000
12/31/2021 5,000   12,700
12/31/2021 5,000   12,700
12/20/2021 53,500   0
12/20/2021 53,500   0
12/17/2021 5,000   12,750
12/17/2021 5,000   12,750
11/24/2021 160,500   0
11/24/2021 160,500   0
11/12/2021 5,000   15,200
11/12/2021 5,000   15,200
09/30/2021 196   631
09/30/2021 196   631
09/30/2021 196   631
09/30/2021 196   631
09/30/2021 196   631
09/30/2021 196   631
09/23/2021 5,000   15,000
09/23/2021 5,000   15,000
09/09/2021 21,000   0
09/09/2021 21,000   0
08/18/2021 5,000   13,850
08/18/2021 5,000   13,850
08/18/2021 500   1,435
08/18/2021 500   1,435
06/30/2021 2,500   18,325
06/30/2021 2,500   18,325
06/22/2021 1,800   12,780
06/22/2021 1,800   12,780
06/21/2021 2,000   14,580
06/21/2021 2,000   14,580
06/18/2021 1,000   7,240
06/18/2021 1,000   7,240
03/11/2021 700   4,739
03/11/2021 700   4,739
03/08/2021 300   2,244
03/08/2021 300   2,244
03/08/2021 3,500   25,900
03/08/2021 3,500   25,900
03/23/2020 1,900   3,306
03/23/2020 1,900   3,306
03/23/2020 100   173
03/23/2020 100   173
03/23/2020 4,000   6,000
03/23/2020 4,000   6,000
03/11/2020 2,000   6,000
03/11/2020 2,000   6,000
03/09/2020 300   1,017
03/09/2020 300   1,017
03/09/2020 4,700   15,980
03/09/2020 4,700   15,980
03/06/2020 2,000   7,480
03/06/2020 2,000   7,480
03/04/2020 200   788
03/04/2020 200   788
03/04/2020 1,800   7,110
03/04/2020 1,800   7,110
03/04/2020 1,800   7,020
03/04/2020 1,800   7,020
03/03/2020 500   1,945
03/03/2020 500   1,945
03/03/2020 200   800
03/03/2020 200   800
03/03/2020 4,300   16,770
03/03/2020 4,300   16,770
09/12/2019 1,000   3,810
09/12/2019 1,000   3,810
09/10/2019 500   1,875
09/10/2019 500   1,875
09/10/2019 500   1,875
09/10/2019 500   1,875
09/10/2019 500   1,880
09/10/2019 500   1,880
09/10/2019 500   1,880
09/10/2019 500   1,880
09/06/2019 500   1,875
09/06/2019 500   1,875
09/04/2019 1,000   3,840
09/04/2019 1,000   3,840
08/27/2019 5,000   18,750
08/27/2019 5,000   18,750
08/27/2019 500   1,870
08/27/2019 500   1,870
08/27/2019 100   380
08/27/2019 100   380
12/19/2018 454,085   0
12/19/2018 454,085   0
12/19/2018 9,356,676   0
12/19/2018 9,356,676   0
12/19/2018 4,559,335   0
12/19/2018 4,559,335   0
12/19/2018 1,867   0
12/19/2018 1,867   0
12/19/2018 454,085   0
12/19/2018 454,085   0
12/19/2018 1,867   0
12/19/2018 1,867   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0
10/16/2018 0   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.